Benefits and risks of inhaled glucocorticoids in children with persistent asthma
Author:
- 1 November 1998
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 102 (5) , S77-S84
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Montelukast for Chronic Asthma in 6- to 14-Year-Old ChildrenJAMA, 1998
- Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthmaPediatric Pulmonology, 1997
- Inhaled Steroids and the Risk of Hospitalization for AsthmaJAMA, 1997
- Cross‐sectional study of bone density in asthmatic childrenPediatric Pulmonology, 1995
- Management of Steroid-Resistant AsthmaClinical Immunotherapeutics, 1995
- Integrated plasma cortisol concentration in children with asthma receiving long‐term inhaled corticosteroidsPediatric Pulmonology, 1992
- Changes in carbohydrate and lipid metabolism in children with asthma inhaling budesonideJournal of Allergy and Clinical Immunology, 1991
- Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonideJournal of Allergy and Clinical Immunology, 1988
- Extrapulmonary effects of maintenance corticosteroid therapy with alternate-day prednisone and inhaled beclomethasone in children with chronic asthmaJournal of Allergy and Clinical Immunology, 1987
- Short stature and delayed skeletal maturation in children with allergic diseaseJournal of Allergy and Clinical Immunology, 1982